Compounds > 3-o-methyl-alpha-methyldopamine
Page last updated: 2024-09-05

3-o-methyl-alpha-methyldopamine and alpha-methyldopamine

3-o-methyl-alpha-methyldopamine has been researched along with alpha-methyldopamine in 3 studies

Compound Research Comparison

Studies
(3-o-methyl-alpha-methyldopamine)		Trials
(3-o-methyl-alpha-methyldopamine)		Recent Studies (post-2010)
(3-o-methyl-alpha-methyldopamine)		Studies
(alpha-methyldopamine)		Trials
(alpha-methyldopamine)		Recent Studies (post-2010) (alpha-methyldopamine)
15014929

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hsu, FL; Yeh, SY1
McCann, UD; Ricaurte, GA1
Ensslin, HK; Kovar, KA; Maurer, HH1

Other Studies

3 other study(ies) available for 3-o-methyl-alpha-methyldopamine and alpha-methyldopamine

ArticleYear
The neurochemical and stimulatory effects of putative metabolites of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine in rats.
    Pharmacology, biochemistry, and behavior, 1991, Volume: 39, Issue:3

    Topics: 3,4-Methylenedioxyamphetamine; Animals; Brain Chemistry; Central Nervous System Stimulants; Cerebral Cortex; Deoxyepinephrine; Dopamine; Epinephrine; Hydroxyindoleacetic Acid; Male; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Nordefrin; Rats; Rats, Inbred Strains; Serotonin

1991
Major metabolites of (+/-)3,4-methylenedioxyamphetamine (MDA) do not mediate its toxic effects on brain serotonin neurons.
    Brain research, 1991, Apr-05, Volume: 545, Issue:1-2

    Topics: 3,4-Methylenedioxyamphetamine; Animals; Brain; Cerebral Cortex; Cerebral Ventricles; Corpus Striatum; Deoxyepinephrine; Dopamine; Functional Laterality; Hippocampus; Injections, Intraventricular; Male; Neurons; Organ Specificity; Rats; Rats, Inbred Strains; Serotonin

1991
Toxicological detection of the designer drug 3,4-methylenedioxyethylamphetamine (MDE, "Eve") and its metabolites in urine by gas chromatography-mass spectrometry and fluorescence polarization immunoassay.
    Journal of chromatography. B, Biomedical applications, 1996, Aug-30, Volume: 683, Issue:2

    Topics: 3,4-Methylenedioxyamphetamine; Administration, Oral; Amphetamines; Deoxyepinephrine; Designer Drugs; Dopamine; Fluorescence Polarization Immunoassay; Gas Chromatography-Mass Spectrometry; Hallucinogens; Humans; Time Factors

1996